A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy-Reference-Cited by-同舟云学术

A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy

Published:2024-02 Issue:1 Volume:14 Page:
ISSN:2163-0402
Container-title:Neurology Clinical Practice
language:en
Short-container-title:Neur Clin Pract

Author:

Gandelman Stephanie¹^ORCID,Lenzi Kerry A.¹^ORCID,Markowitz Clyde¹^ORCID,Berger Joseph R.¹^ORCID

Affiliation:

1. Department of Neurology (SG, CM, JRB), University of Pennsylvania Perelman School of Medicine, Philadelphia; Department of Neurology (SG), New York Medical College, Valhalla; and Department of Pharmacy (KAL), Hospital of the University of Pennsylvania, Philadelphia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/CPJ.0000000000200241

Reference42 articles.

1. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

2. Ocrevus Full Prescribing Information. 2017. Accessed November 29. 2022. accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf.

3. Kesimpta Full Prescribing Information. 2020. Accessed December 10, 2022. accessdata.fda.gov/drugsatfda_docs/label/2020/125326s070lbl.pdf.

4. Routine Laboratory Measures in the Controlled-Treatment Period of Phase III Ocrelizumab Trials in Relapsing and Progressive Multiple Sclerosis (P5.425)

5. The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-cell Depletion Therapy in Pediatric Neuroinflammatory Disease;Current Neurology and Neuroscience Reports;2024-09-11